These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25173805)

  • 21. Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson.
    Tassone A; Meringolo M; Ponterio G; Bonsi P; Schirinzi T; Martella G
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin E and neurodegenerative diseases.
    Ricciarelli R; Argellati F; Pronzato MA; Domenicotti C
    Mol Aspects Med; 2007; 28(5-6):591-606. PubMed ID: 17306357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.
    Cai H; Cong WN; Ji S; Rothman S; Maudsley S; Martin B
    Curr Alzheimer Res; 2012 Jan; 9(1):5-17. PubMed ID: 22329649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation.
    Zolezzi JM; Santos MJ; Bastías-Candia S; Pinto C; Godoy JA; Inestrosa NC
    Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2046-2069. PubMed ID: 28220655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.
    Mattson MP; Shea TB
    Trends Neurosci; 2003 Mar; 26(3):137-46. PubMed ID: 12591216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Ghrelin in Senescence: A Mini-Review.
    Yin Y; Zhang W
    Gerontology; 2016; 62(2):155-62. PubMed ID: 26160147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Looking backward to move forward: early detection of neurodegenerative disorders.
    DeKosky ST; Marek K
    Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurodegenerative conditions associated with ageing: a molecular interplay?
    Troulinaki K; Tavernarakis N
    Mech Ageing Dev; 2005 Jan; 126(1):23-33. PubMed ID: 15610759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin hormone as a therapeutic weapon against neurodegenerative diseases.
    Asefy Z; Khusro A; Mammadova S; Hoseinnejhad S; Eftekhari A; Alghamdi S; Dablool AS; Almehmadi M; Kazemi E; Sahibzada MUK
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):99-106. PubMed ID: 34933727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contribution of the study of neurodegenerative disorders to the understanding of human memory.
    Panegyres PK
    QJM; 2004 Sep; 97(9):555-67. PubMed ID: 15317924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.
    Teixeira AL; Barbosa IG; Diniz BS; Kummer A
    Biomark Med; 2010 Dec; 4(6):871-87. PubMed ID: 21133708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
    Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal attenuating therapies in neurodegenerative disease.
    Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
    Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ghrelin in mental health, sleep, memory.
    Steiger A; Dresler M; Schüssler P; Kluge M
    Mol Cell Endocrinol; 2011 Jun; 340(1):88-96. PubMed ID: 21349316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease.
    Gahete MD; Córdoba-Chacón J; Kineman RD; Luque RM; Castaño JP
    Peptides; 2011 Nov; 32(11):2225-8. PubMed ID: 21983104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
    Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of obesity on neurodegenerative diseases.
    Mazon JN; de Mello AH; Ferreira GK; Rezin GT
    Life Sci; 2017 Aug; 182():22-28. PubMed ID: 28583368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.